Evidence map›Paper›PMID 24242184›Full record

ArticleHuman molecular genetics2014

A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium.

Roger L Milne, Jesús Herranz, Kyriaki Michailidou, Joe Dennis, Jonathan P Tyrer, M Pilar Zamora, José Ignacio Arias-Perez, Anna González-Neira, Guillermo Pita, M Rosario Alonso and 137 more

Abstract read
In one paragraph

Article in Human molecular genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Can classical statistics and deep learning converge on explainable, causally driven target discovery?DNA research : an international journal for rapid publication of reports on genes and genomes · 2025
    Review
  2. Article
  3. A Large-Scale Genome-Wide Gene-Gene Interaction Study of Lung Cancer Susceptibility in Europeans With a Trans-Ethnic Validation in Asians.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2022
    Article
  4. DNA Mismatch Repair Gene Variants in Sporadic Solid Cancers.International journal of molecular sciences · 2020
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Combinations of Genetic Variants Occurring Exclusively in Patients.Computational and structural biotechnology journal · 2017
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

147 authors.

Roger L MilneHuman Cancer Genetics Programme and.
Jesús Herranz
Kyriaki Michailidou
Joe Dennis
Jonathan P Tyrer
M Pilar Zamora
José Ignacio Arias-Perez
Anna González-Neira
Guillermo Pita
M Rosario Alonso
Qin Wang
Manjeet K Bolla
Kamila Czene
Mikael Eriksson
Keith Humphreys
Hatef Darabi
Jingmei Li
Hoda Anton-Culver
Susan L Neuhausen
Argyrios Ziogas
Christina A Clarke
John L Hopper
Gillian S Dite
Carmel Apicella
Melissa C Southey
Georgia Chenevix-Trench
kConFab Investigators
Australian Ovarian Cancer Study Group
Anthony Swerdlow
Alan Ashworth
Nicholas Orr
Minouk Schoemaker
Anna Jakubowska
Jan Lubinski
Katarzyna Jaworska-Bieniek
Katarzyna Durda
Irene L Andrulis
Julia A Knight
Gord Glendon
Anna Marie Mulligan
Stig E Bojesen
Børge G Nordestgaard
Henrik Flyger
Heli Nevanlinna
Taru A Muranen
Kristiina Aittomäki
Carl Blomqvist
Jenny Chang-Claude
Anja Rudolph
Petra Seibold
Dieter Flesch-Janys
Xianshu Wang
Janet E Olson
Celine Vachon
Kristen Purrington
Robert Winqvist
Katri Pylkäs
Arja Jukkola-Vuorinen
Mervi Grip
Alison M Dunning
Mitul Shah
Pascal Guénel
Thérèse Truong
Marie Sanchez
Claire Mulot
Hermann Brenner
Aida Karina Dieffenbach
Volker Arndt
Christa Stegmaier
Annika Lindblom
Sara Margolin
Maartje J Hooning
Antoinette Hollestelle
J Margriet Collée
Agnes Jager
Angela Cox
Ian W Brock
Malcolm W R Reed
Peter Devilee
Robert A E M Tollenaar
Caroline Seynaeve
Christopher A Haiman
Brian E Henderson
Fredrick Schumacher
Loic Le Marchand
Jacques Simard
Martine Dumont
Penny Soucy
Thilo Dörk
Natalia V Bogdanova
Ute Hamann
Asta Försti
Thomas Rüdiger
Hans-Ulrich Ulmer
Peter A Fasching
Lothar Häberle
Arif B Ekici
Matthias W Beckmann
Olivia Fletcher
Nichola Johnson
Isabel dos Santos Silva
Julian Peto
Paolo Radice
Paolo Peterlongo
Bernard Peissel
Paolo Mariani
Graham G Giles
Gianluca Severi
Laura Baglietto
Elinor Sawyer
Ian Tomlinson
Michael Kerin
Nicola Miller
Federik Marme
Barbara Burwinkel
Arto Mannermaa
Vesa Kataja
Veli-Matti Kosma
Jaana M Hartikainen
Diether Lambrechts
Betul T Yesilyurt
Giuseppe Floris
Karin Leunen
Grethe Grenaker Alnæs
Vessela Kristensen
Anne-Lise Børresen-Dale
Montserrat García-Closas
Stephen J Chanock
Jolanta Lissowska
Jonine D Figueroa
Marjanka K Schmidt
Annegien Broeks
Senno Verhoef
Emiel J Rutgers
Hiltrud Brauch
Thomas Brüning
Yon-Dschun Ko
GENICA Network
Fergus J Couch
Amanda E Toland
TNBCC
Drakoulis Yannoukakos
Paul D P Pharoah
Per Hall
Javier Benítez
Núria Malats
Douglas F Easton

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
The Role of CHFR in Tumorigenesis and Paclitaxel-Sensitivity in Breast CancerP50CA116201 · NCI · MAYO CLINIC ROCHESTER · PI PETER C LUCAS · 2005 to 2026
$49.9M
CALIFORNIA TEACHERS STUDYR01CA077398 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BERNSTEIN, LESLIE · 1998 to 2014
$29.7M
GENETIC SUSCEPTIBILITY TO CANCER IN MULTIETHNIC COHORTSR01CA063464 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HENDERSON, BRIAN E · 2001 to 2005
$23.2M
Multiethnic Cohort Study of Diet and CancerR37CA054281 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI KOLONEL, LAURENCE N. · 2003 to 2012
$23.2M
Breast Cancer Family Registry CohortUM1CA164920 · NCI · CANCER PREVENTION INSTIT OF CALIFORNIA · PI ANDRULIS, IRENE, BUYS, SAUNDRA S · 2012 to 2017
$12.7M
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3U01CA098758 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HENDERSON, BRIAN E · 2003 to 2010
$11.0M
Epidemiologic StudiesU19CA148065 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI AHSAN, HABIBUL, BRUGGE, JOAN SIEFERT · 2010 to 2014
$10.6M
Epidemiological and Clinical Translational Studies Post Genome-Wide AssociationU19CA148537 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI EASTON, DOUGLAS FREDERICK, EELES, ROSALIND · 2010 to 2014
$10.4M
Ovarian cancer GWAS discovery, expansion and replication (N2 - Project #1)U19CA148112 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI SELLERS, THOMAS A · 2010 to 2014
$10.2M
A genome-wide association study for breast cancer in BRCA1 mutation carriersR01CA128978 · NCI · MAYO CLINIC ROCHESTER · PI COUCH, FERGUS JOSEPH · 2008 to 2012
$4.8M
MULTIETHNIC/MINORITY COHORT STUDY OF DIET AND CANCERR01CA054281 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI KOLONEL, LAURENCE N. · 1993 to 2002
$4.5M
Breast Cancer Now BREAST CANCER NOW RESEARCH CENTRECancer Research UK 10118Cancer Research UK 10124Cancer Research UK 11022Cancer Research UK 16561Cancer Research UK 16563Cancer Research UK 16565Cancer Research UK C12292/A11174Cancer Research UK C1281/A12014Cancer Research UK C1287/A10118Cancer Research UK C1287/A 10710Cancer Research UK C1287/A12014Cancer Research UK C490/A10124Cancer Research UK C5047/A10692Cancer Research UK C5047/A15007Cancer Research UK C5047/A8384CIHRNCI NIH HHS 1U19 CA148065NCI NIH HHS 1U19 CA148112NCI NIH HHS 1U19 CA148537NCI NIH HHS CA098758NCI NIH HHS CA122340NCI NIH HHS (CA128978NCI NIH HHS CA128978NCI NIH HHS CA132839NCI NIH HHS CA54281NCI NIH HHS CA63464NCI NIH HHS P30 CA015083NCI NIH HHS P50 CA116201NCI NIH HHS R01 CA054281NCI NIH HHS R01 CA063464NCI NIH HHS R01 CA077398NCI NIH HHS R01 CA122340NCI NIH HHS R01 CA128978NCI NIH HHS R01 CA132839NCI NIH HHS R01CA77398NCI NIH HHS R37 CA054281NCI NIH HHS U01 CA063464NCI NIH HHS U01 CA098758NCI NIH HHS U19 CA148065NCI NIH HHS U19 CA148112NCI NIH HHS U19 CA148537NCI NIH HHS UM1 CA164920Wellcome Trust 090532
6 · The paper itself

Abstract

Part of the substantial unexplained familial aggregation of breast cancer may be due to interactions between common variants, but few studies have had adequate statistical power to detect interactions of realistic magnitude. We aimed to assess all two-way interactions in breast cancer susceptibility between 70,917 single nucleotide polymorphisms (SNPs) selected primarily based on prior evidence of a marginal effect. Thirty-eight international studies contributed data for 46,450 breast cancer cases and 42,461 controls of European origin as part of a multi-consortium project (COGS). First, SNPs were preselected based on evidence (P < 0.01) of a per-allele main effect, and all two-way combinations of those were evaluated by a per-allele (1 d.f.) test for interaction using logistic regression. Second, all 2.5 billion possible two-SNP combinations were evaluated using Boolean operation-based screening and testing, and SNP pairs with the strongest evidence of interaction (P < 10(-4)) were selected for more careful assessment by logistic regression. Under the first approach, 3277 SNPs were preselected, but an evaluation of all possible two-SNP combinations (1 d.f.) identified no interactions at P < 10(-8). Results from the second analytic approach were consistent with those from the first (P > 10(-10)). In summary, we observed little evidence of two-way SNP interactions in breast cancer susceptibility, despite the large number of SNPs with potential marginal effects considered and the very large sample size. This finding may have important implications for risk prediction, simplifying the modelling required. Further comprehensive, large-scale genome-wide interaction studies may identify novel interacting loci if the inherent logistic and computational challenges can be overcome.

Indexed as

Genetic Predisposition to DiseaseBreast NeoplasmsCase-Control StudiesEpistasis, GeneticFemaleGenome-Wide Association StudyHumansLogistic ModelsPolymorphism, Single Nucleotide

Identifiers

PMID24242184
PMCPMC3943524

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.